ARCHIVES

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

White House Estimates Automatic Budget Cuts Would Take 8.2 Percent From NCI, NIH and FDA

September 21, 2012

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011